The Effect of Bevacizumab (Avastin) on Pterygium

Completed · Phase 2

Conditions studied: Pterygium

In brief

The purpose of this study is to determine whether local injection of bevacizumab might halt and or cause regression of pterygium growth. This may enable earlier treatment and prevention of pterygium growth into the patient's line of sight thereby limiting the need for surgery and improving quality of life for patients with pterygia.

Key facts

Study ID

NCT00592176

Run by

University of Alabama at Birmingham

People needed

5

Starts

2007-08-01

Expected to finish

2010-03-01

Last updated by the study team

2014-06-04

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 19 years of age and older
• Diagnosis of pterygia
• healthy enough to make scheduled follow-up visits

You may not qualify if…

• Women of childbearing potential and males who plan to father a child during their participation in the study will be excluded from the study.

Where it is running

• Callahan Eye Foundation Hospital — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.